At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 crowley, john f Mar 18, 2013 24.7 KB View HTML View PDF View XLS  
4 barer, sol j Mar 18, 2013 24.2 KB View HTML View PDF View XLS  
3 macaluso peter m Feb 11, 2013 29.1 KB View HTML View PDF View XLS  
3 gershkowitz jayne Feb 11, 2013 29.9 KB View HTML View PDF View XLS  
3 castelli jeff Feb 11, 2013 30.2 KB View HTML View PDF View XLS  
4 kirk, john Jan 30, 2013 24.4 KB View HTML View PDF View XLS  
4 dilone, enrique Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
4 valenzano, ken Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
4 peist, kenneth Jan 30, 2013 22.9 KB View HTML View PDF View XLS  
4 crowley, john f Jan 30, 2013 24.4 KB View HTML View PDF View XLS  
4 campbell, bradley l Jan 30, 2013 24.5 KB View HTML View PDF View XLS  
4 baird, william d iii Jan 30, 2013 23.0 KB View HTML View PDF View XLS  
4 lockhart, david j Jan 30, 2013 24.4 KB View HTML View PDF View XLS  
4 winterbottom, joan Jan 30, 2013 24.5 KB View HTML View PDF View XLS  
4 quimi, daphne Jan 30, 2013 25.3 KB View HTML View PDF View XLS  
4 winterbottom, joan Nov 14, 2012 22.2 KB View HTML View PDF View XLS  
4 winterbottom, joan Aug 30, 2012 24.7 KB View HTML View PDF View XLS  
3 winterbottom joan Aug 30, 2012 22.0 KB View HTML View PDF View XLS  
4 glaxosmithkline, plc Jul 17, 2012 24.0 KB View HTML View PDF View XLS  
4 essner, robert Jul 11, 2012 24.5 KB View HTML View PDF View XLS  
Showing 1-20 of 458 Page: 1 2 3 4 5 ... 23  Next 20

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy